This is an exciting time to be involved in cancer therapeutics. The sequencing of the human genome has enormously expanded our awareness and understanding of how cancer cells gain autonomy and immortality by subverting the function of normal cell receptors and pathways. This has revolutionised the way in which anti-cancer therapies are viewed hence the underlying pharmacology of new cancer drugs. In both the laboratory and the clinic, cancer pharmacology has had to adapt to this changing face of drug development by establishing new experimental and target-orientated models.
The course benefits from the multidisciplinary team of researchers in the field of anti-cancer drug design, synthesis, screening and pharmacology both at Bradford and through our extensive links with experts at other universities and industry.
Molecular Basis of Cancer and Cancer Therapy
Pre-clinical Models for Drug Development
International Student Requirements:
English language requirements: IELTS at 6.0 or the equivalent.